Kidney research reveals a complex picture of life-saving treatments that show genuine promise but deliver frustratingly mixed ...
Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more about RZLT stock here.
This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...
TipRanks on MSN
MicroPort NeuroTech steps up competition in brain vascular devices with new embolic agent trial
MicroPort NeuroTech Limited ($HK:2172) announced an update on their ongoing clinical study. Study Overview The clinical study “a Prospective, ...
Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...
Morning Overview on MSN
Discovery could one day reverse osteoporosis, scientists say
For decades, osteoporosis has meant a slow, one way slide toward fragile bones and fracture risk, managed but rarely truly ...
This architectural design book focuses on massing studies for multi-unit housing projects, namely apartment blocks; it provides a fresh look at architectural synthesis for architects, students and ...
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...
Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approvalInitiation of the ...
Why it's essential to combine sign-off accuracy, iterative feedback, and intelligent automation in complex designs.
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
A woman has spoken out about how her decision to transition to a male between ages of 12 and 16 caused irreversible health affects. On Thursday, de-transitioner Chloe Cole, 21, spoke in favor of new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results